HNB
SNDX icon

Huntington National Bank’s Syndax Pharmaceuticals SNDX Stock Holding History

Huntington National Bank’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-253
Closed -$3.11K – 4224
2025
Q1 		$3.11K Hold
253
– – ﹤0.01% 2119
2024
Q4 		$3.35K Buy
253
+17
+7% +$291 ﹤0.01% 2124
2024
Q3 		$4.54K Buy
+236
New +$4.88K ﹤0.01% 2028
2020
Q4 		– Sell
-100
Closed -$1K – 1786
2020
Q3 		$1K Buy
+100
New +$1.52K ﹤0.01% 1488

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Huntington National Bank's SNDX Position: Q2 2025 in Review

Huntington National Bank sold out of Syndax Pharmaceuticals (SNDX) in Q2 2025, closing a stake of 253 shares — an estimated $3.11K sold.

Huntington National Bank first reported a position in SNDX in Q3 2020 and held it in 4 quarters. The position peaked at $4.54K in Q3 2024. 216 funds tracked by Wall St. Rank hold SNDX as of Q2 2025.

  • Huntington National Bank reported no remaining Syndax Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Huntington National Bank sold 253 Syndax Pharmaceuticals shares in Q2 2025, an estimated $3.11K.
  • Huntington National Bank first reported a position in Syndax Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Huntington National Bank's Syndax Pharmaceuticals position peaked at $4.54K in Q3 2024.
  • 216 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2025.

Based on Huntington National Bank's 13F filing for Q2 2025, filed 5 Aug 2025.